title: Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'.
authors.forename: Lucy J
authors.initials: LJ
authors.lastname: Garvey
authors.forename: Emma C
authors.initials: EC
authors.lastname: Thomson
authors.forename: Josephine
authors.initials: J
authors.lastname: Lloyd
authors.forename: Graham S
authors.initials: GS
authors.lastname: Cooke
authors.forename: Robert D
authors.initials: RD
authors.lastname: Goldin
authors.forename: Janice
authors.initials: J
authors.lastname: Main
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000473:pathology / Q000821:virology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D015497:HIV-1; D006801:Humans; D006965:Hyperplasia; D006975:Hypertension, Portal / Q000150:complications / Q000473:pathology / Q000821:virology; D008099:Liver / Q000473:pathology / Q000821:virology; D008107:Liver Diseases / Q000473:pathology / Q000821:virology*; D008115:Liver Regeneration; D008875:Middle Aged
chemical_list: D044966:Anti-Retroviral Agents; D016049:Didanosine